|
Status |
Public on Dec 10, 2009 |
Title |
Quercetin supplementation and CD14+ monocyte gene expression |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by array
|
Summary |
Quercetin has been described to have a wide range of beneficial effects in humans, ranging from anti-carcinogenic properties to reduced risk of cardiovascular disease. We tested whether a daily supplementation of quercetin leads to reproducible changes in gene expression profiles of human monocytes. Keywords: individual compound treatment
|
|
|
Overall design |
CD14+ monocytes were isolated from three healthy volunteers before and after a 2 wk supplementation period of 150mg quercetin per day. With this design every subject served as his or her own control (baseline sample = control)
|
|
|
Contributor(s) |
Döring F, Boomgaarden I |
Citation(s) |
20416132 |
|
Submission date |
Dec 10, 2008 |
Last update date |
Mar 25, 2019 |
Contact name |
Frank Döring |
E-mail(s) |
sek@molprev.uni-kiel.de
|
Organization name |
Christian-Albrechts-University Kiel
|
Department |
Human Nutrition and Food Science
|
Street address |
Heinrich-Hecht-Platz 10
|
City |
Kiel |
ZIP/Postal code |
24118 |
Country |
Germany |
|
|
Platforms (1) |
GPL570 |
[HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array |
|
Samples (6)
|
GSM350084 |
CD14+ at baseline, biological replicate 1 |
GSM350085 |
CD14+ at baseline, biological replicate 2 |
GSM350086 |
CD14+ at baseline, biological replicate 3 |
GSM350087 |
CD14+ after 2 wk quercetin supplementation, biological replicate 1 |
GSM350088 |
CD14+ after 2 wk quercetin supplementation, biological replicate 2 |
GSM350089 |
CD14+ after 2 wk quercetin supplementation, biological replicate 3 |
|
Relations |
BioProject |
PRJNA110307 |